Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...
The first pills are expected to hit the market next month and attract people who don’t want to give themselves shots.
Lilly has a new pill, called orforglipron, it plans to launch next year. On Thursday, the company reported the results of a ...
One of these companies should lead this market, but both could be attractive buys.
A pill version of the GLP-1 weight-loss drug Wegovy is expected to debut in the U.S. in early January. But how will the pills ...
The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight ...
Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
Using GLP-1s or considering it? New global research reveals social and psychological consequences for everyday lives.
The changing market is forcing the drugmakers to hire people with more consumer-focused expertise, strike more deals with ...
The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...
Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback